GermlineMutationDoxorubicinGeneticPredispositionMorpheaNodeNegativeOvarianSuppressionMultimodalityTherapyDimplingCytotoxicCytostaticTriplePositiveBreastCancerFISHACChemotherapyPagetDiseaseCMFChemotherapyFamilyHistoryBreastTomosynthesisTripleNegativeBreastCancerPhysicalactivity mayreduce therisk of breastcancersMegestrolAcetateImmunotherapyBRCAGeneAnastrozoleNeoadjuvantTherapyPARPInhibitorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEGFR(epidermalgrowth factorreceptor)MultifocalTumorsER-CheckpointInhibitorECOGScoreBI-RADSWomen ages40+ shouldhave a clinicalbreast examat least yearlyGeneticCounselingHormoneReceptorStatusInvasiveBreastCancerMethotrexate1 in 8womenAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerGuaranteedRenewableInsuranceDoseDenseTherapyNeoplasmWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.FibroadenomaLymphNodeStatusAlopeciaAntibodyTherapyPalpationAdjuvantTherapyLumpAromataseInhibitorsPalbociclibFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CalcificationsAntiemeticBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55ApoptosisCyclophosphamideNodePositiveOligometastasesAxillarySamplingDocetaxelmTORInhibitorsCachexiaRadiotherapyPrecisionMedicineCapecitabineBOCASelf-examinationHormoneReplacementTherapyFlowCytometryCystGailModel5-FluorouracilKi-67RateStagingLymphoscintigraphyAbsoluteRiskMetastasisAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenHER-2GenomicTestingLapatinibBiopsyRelapseMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPathologicResponseEstrogenExcisionalBiopsyTamoxifenMastodyniaBrachytherapySERMTumorGradeMastectomyER+PI3KinaseInhibitorsBevacizumabGeneMutationDown-StagingLumpectomyTyrosine-KinaseInhibitorPaclitaxelIn-situCarcinomaBilateralProphylacticMastectomyDefinitiveSurgeryIntraductalPapillomaHerceptinCo-survivorBreastCancerAyurvedaRaloxifeneCAMCDK4/6InhibitorsKappaEpsilonMRIAngiogenesisChemopreventionPhyllodesTumorProgestinEstradiolLCISAdenocarcinomaChemotherapyRADAdvocacyGermlineMutationDoxorubicinGeneticPredispositionMorpheaNodeNegativeOvarianSuppressionMultimodalityTherapyDimplingCytotoxicCytostaticTriplePositiveBreastCancerFISHACChemotherapyPagetDiseaseCMFChemotherapyFamilyHistoryBreastTomosynthesisTripleNegativeBreastCancerPhysicalactivity mayreduce therisk of breastcancersMegestrolAcetateImmunotherapyBRCAGeneAnastrozoleNeoadjuvantTherapyPARPInhibitorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEGFR(epidermalgrowth factorreceptor)MultifocalTumorsER-CheckpointInhibitorECOGScoreBI-RADSWomen ages40+ shouldhave a clinicalbreast examat least yearlyGeneticCounselingHormoneReceptorStatusInvasiveBreastCancerMethotrexate1 in 8womenAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerGuaranteedRenewableInsuranceDoseDenseTherapyNeoplasmWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.FibroadenomaLymphNodeStatusAlopeciaAntibodyTherapyPalpationAdjuvantTherapyLumpAromataseInhibitorsPalbociclibFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CalcificationsAntiemeticBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55ApoptosisCyclophosphamideNodePositiveOligometastasesAxillarySamplingDocetaxelmTORInhibitorsCachexiaRadiotherapyPrecisionMedicineCapecitabineBOCASelf-examinationHormoneReplacementTherapyFlowCytometryCystGailModel5-FluorouracilKi-67RateStagingLymphoscintigraphyAbsoluteRiskMetastasisAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenHER-2GenomicTestingLapatinibBiopsyRelapseMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPathologicResponseEstrogenExcisionalBiopsyTamoxifenMastodyniaBrachytherapySERMTumorGradeMastectomyER+PI3KinaseInhibitorsBevacizumabGeneMutationDown-StagingLumpectomyTyrosine-KinaseInhibitorPaclitaxelIn-situCarcinomaBilateralProphylacticMastectomyDefinitiveSurgeryIntraductalPapillomaHerceptinCo-survivorBreastCancerAyurvedaRaloxifeneCAMCDK4/6InhibitorsKappaEpsilonMRIAngiogenesisChemopreventionPhyllodesTumorProgestinEstradiolLCISAdenocarcinomaChemotherapyRADAdvocacy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Germline Mutation
  2. Doxorubicin
  3. Genetic Predisposition
  4. Morphea
  5. Node Negative
  6. Ovarian Suppression
  7. Multimodality Therapy
  8. Dimpling
  9. Cytotoxic
  10. Cytostatic
  11. Triple Positive Breast Cancer
  12. FISH
  13. AC Chemotherapy
  14. Paget Disease
  15. CMF Chemotherapy
  16. Family History
  17. Breast Tomosynthesis
  18. Triple Negative Breast Cancer
  19. Physical activity may reduce the risk of breast cancers
  20. Megestrol Acetate
  21. Immunotherapy
  22. BRCA Gene
  23. Anastrozole
  24. Neoadjuvant Therapy
  25. PARP Inhibitors
  26. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  27. EGFR (epidermal growth factor receptor)
  28. Multifocal Tumors
  29. ER-
  30. Checkpoint Inhibitor
  31. ECOG Score
  32. BI-RADS
  33. Women ages 40+ should have a clinical breast exam at least yearly
  34. Genetic Counseling
  35. Hormone Receptor Status
  36. Invasive Breast Cancer
  37. Methotrexate
  38. 1 in 8 women
  39. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  40. Guaranteed Renewable Insurance
  41. Dose Dense Therapy
  42. Neoplasm
  43. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  44. Fibroadenoma
  45. Lymph Node Status
  46. Alopecia
  47. Antibody Therapy
  48. Palpation
  49. Adjuvant Therapy
  50. Lump
  51. Aromatase Inhibitors
  52. Palbociclib
  53. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  54. Calcifications
  55. Antiemetic
  56. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  57. Apoptosis
  58. Cyclophosphamide
  59. Node Positive
  60. Oligometastases
  61. Axillary Sampling
  62. Docetaxel
  63. mTOR Inhibitors
  64. Cachexia
  65. Radiotherapy
  66. Precision Medicine
  67. Capecitabine
  68. BOCA
  69. Self-examination
  70. Hormone Replacement Therapy
  71. Flow Cytometry
  72. Cyst
  73. Gail Model
  74. 5-Fluorouracil
  75. Ki-67 Rate
  76. Staging
  77. Lymphoscintigraphy
  78. Absolute Risk
  79. Metastasis
  80. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  81. HER-2
  82. Genomic Testing
  83. Lapatinib
  84. Biopsy
  85. Relapse
  86. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  87. Pathologic Response
  88. Estrogen
  89. Excisional Biopsy
  90. Tamoxifen
  91. Mastodynia
  92. Brachytherapy
  93. SERM
  94. Tumor Grade
  95. Mastectomy
  96. ER+
  97. PI3 Kinase Inhibitors
  98. Bevacizumab
  99. Gene Mutation
  100. Down-Staging
  101. Lumpectomy
  102. Tyrosine-Kinase Inhibitor
  103. Paclitaxel
  104. In-situ Carcinoma
  105. Bilateral Prophylactic Mastectomy
  106. Definitive Surgery
  107. Intraductal Papilloma
  108. Herceptin
  109. Co-survivor
  110. Breast Cancer
  111. Ayurveda
  112. Raloxifene
  113. CAM
  114. CDK4/6 Inhibitors
  115. Kappa Epsilon
  116. MRI
  117. Angiogenesis
  118. Chemoprevention
  119. Phyllodes Tumor
  120. Progestin
  121. Estradiol
  122. LCIS
  123. Adenocarcinoma
  124. Chemotherapy
  125. RAD
  126. Advocacy